PAG Biological Medicine-B (02565): China Securities Regulatory Commission issues a filing notice for the application of full circulation of the company's H shares.
PacBio Pharmaceuticals-B (02565) announced that the company has received a filing notice from the China Securities Regulatory Commission regarding the implementation of full circulation of H shares, dated March 26, 2026. According to the filing notice, the company has completed the filing with the China Securities Regulatory Commission for the full circulation of H shares totaling 1.02 billion shares of unlisted shares. If the share conversion is not completed within 12 months from the date of the filing notice, and the company still intends to proceed with the conversion, the company shall update the filing materials with the China Securities Regulatory Commission. The company will apply to the Hong Kong Stock Exchange for approval for the listing and trading of such H shares on the main board of the Stock Exchange.
Paxgen Biopharmaceuticals-B (02565) announced that the company has received a filing notice from the China Securities Regulatory Commission regarding the implementation of the full circulation of H shares with a release date of March 26, 2026. According to the filing notice, the company has completed the filing with the CSRC for the full circulation of a total of 102 million unlisted shares. If the share conversion is not completed within 12 months from the date of the filing notice, and the company still intends to proceed with the conversion, the company must update the filing materials with the CSRC. The company will apply to the Stock Exchange for approval to list and trade these H shares on the main board of the Stock Exchange.
Related Articles
.png)
UNI PRINTSHOP(08448): Guowe appointed as the new auditor.
MICROTECH MED-B (02235) repurchased 35,900 shares at a cost of HK$265,400 on April 9th.
CHINA JINMAO (00817) has accumulated a total signed sales amount of 22.428 billion in the first 3 months, representing a year-on-year increase of 25.54%.
UNI PRINTSHOP(08448): Guowe appointed as the new auditor.
MICROTECH MED-B (02235) repurchased 35,900 shares at a cost of HK$265,400 on April 9th.
CHINA JINMAO (00817) has accumulated a total signed sales amount of 22.428 billion in the first 3 months, representing a year-on-year increase of 25.54%.
